Abstract:OBJECTIVE:To validate the value of dual energy CT (DECT) in the differentiation of mediastinal metastatic lymph nodes from non-metastatic lymph nodes in non-small cell lung cancer (NSCLC).METHODS:In the study, 57 surgically confirmed NSCLC patients who underwent enhanced DECT scan within 2 weeks before operation were enrolled. Two radiologists analyzed the CT images before operation. All mediastinal lymph nodes with short diameter≥5 mm on axial images were included in this study. The morphological parameters [long-axis diameter (L), short-axis diameter (S) and S/L of lymph nodes] and the DECT parameters [iodine concentration (IC), normalized iodine concentration (NIC), slope of spectral hounsfield unit curve (λHU) and effective atomic number (Zeff) in arterial and venous phase] were measured. The differences of morphological parameters and DECT parameters between metastatic and non-metastatic lymph nodes were compared. The parameters with significant difference were analyzed by the Logistic regression model, then a new predictive variable was established. Receiver operator characteristic (ROC) analyses were performed for S, NIC in venous phase and the new predictive variable.RESULTS:In 57 patients, 49 metastatic lymph nodes and 938 non-metastatic lymph nodes were confirmed by surgical pathology. A total of 163 mediastinal lymph nodes (49 metastatic, 114 non-metastatic) with S≥5 mm were detected on axial CT images. The S, L and S/L of metastatic lymph nodes were significantly higher than those of non-metastatic lymph nodes (P < 0.05). The DECT parameters of metastatic lymph nodes were significantly lower than those of non-metastatic lymph nodes (P < 0.05). The best single morphological parameter for differentiation between metastatic and nonmetastatic lymph nodes was S (AUC, 0.752; threshold, 8.5 mm; sensitivity, 67.4%; specificity, 73.7%; accuracy, 71.8%). The best single DECT parameter for differentiation between metastatic and nonmetastatic lymph nodes was NIC in venous phase (AUC, 0.861; threshold, 0.53; sensitivity, 95.9%; specificity, 70.2%; accuracy, 77.9%). Multivariate analysis showed that S and NIC were independent predictors of lymph node metastasis. The AUC of combined S and NIC in the venous phase was 0.895(sensitivity, 79.6%; specificity, 87.7%; accuracy, 85.3%), which were significantly higher than that of S (P < 0.001) and NIC (P=0.037).CONCLUSIONS:The ability of quantitative DECT parameters to distinguish mediastinal lymph node metastasis in NSCLC patients is better than that of morphological parameters. Combined S and NIC in venous phase can be used to improve preoperative diagnostic accuracy of metastatic lymph nodes.

Dual-Energy CT Material Decomposition: The Value in the Detection of Lymph Node Metastasis from Breast Cancer

A Prospective Study of Dual-Energy Computed Tomography for Differentiating Metastatic and Non-Metastatic Lymph Nodes of Colorectal Cancer

Dual-Energy CT for Locoregional Staging of Breast Cancer: Preliminary Results

Differentiation of intrathoracic lymph node histopathology by volumetric dual energy CT radiomic analysis

Dual-Energy Computed Tomography for Evaluation of Breast Cancer Follow-Ups: Comparison of Virtual Monoenergetic Images and Iodine-Map

Preoperative Diagnosis of Regional Lymph Node Metastasis of Colorectal Cancer with Quantitative Parameters from Dual-Energy CT.

Value of Dual-Energy Computed Tomography for Diagnosing Cervical Lymph Node Metastasis in Patients With Papillary Thyroid Cancer.

Evaluation of Dual Energy Spectral CT in Differentiating Metastatic from Non-Metastatic Lymph Nodes in Rectal Cancer: Initial Experience

[Diagnostic Value of Dual Energy CT for Lymph Node Metastasis in Patients with Non-Small Cell Lung Cancer].

Dual-Energy Computed Tomography in Detecting and Predicting Lymph Node Metastasis in Malignant Tumor Patients: A Comprehensive Review

[Comparative Imaging Study of Mediastinal Lymph Node from Pre-Surgery Dual Energy CT Versus Post-Surgeron Verifications in Non-Small Cell Lung Cancer Patients].

Axillary Sentinel Lymph Nodes in Breast Cancer: Quantitative Evaluation at Dual-Energy CT.

Dual-energy Computed Tomography Could Reliably Differentiate Metastatic from Non-Metastatic Lymph Nodes of Less Than 0.5 Cm in Patients with Papillary Thyroid Carcinoma.

Iodine Map Radiomics in Breast Cancer: Prediction of Metastatic Status

A Dual-Energy CT Radiomics of the Regional Largest Short-Axis Lymph Node Can Improve the Prediction of Lymph Node Metastasis in Patients With Rectal Cancer

Dual-Layer Spectral Detector Computed Tomography Quantitative Parameters: A Potential Tool for Lymph Node Activity Determination in Lymphoma Patients

Diagnosis of Metastatic Lymph Nodes in Patients with Hepatocellular Carcinoma Using Dual-Energy Computed Tomography.

Decoupling convolution network for characterizing the metastatic lymph nodes of breast cancer patients

Detection of axillary lymph node metastasis in breast cancer using dual-layer spectral computed tomography

Predicting axillary lymph node metastasis in breast cancer using the similarity of quantitative dual-energy CT parameters between the primary lesion and axillary lymph node

Dual-energy CT quantitative parameters for the differentiation of benign from malignant lesions and the prediction of histopathological and molecular subtypes in breast cancer